{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:40:10Z","timestamp":1770352810424,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12933-017-0573-z","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T08:59:41Z","timestamp":1500454781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner?"],"prefix":"10.1186","volume":"16","author":[{"given":"Alexander","family":"Tenenbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7055-4488","authenticated-orcid":false,"given":"Enrique Z.","family":"Fisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"573_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","volume":"54","author":"RR Packard","year":"2008","unstructured":"Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008;54:24\u201338.","journal-title":"Clin Chem"},{"key":"573_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2840-2-11","volume":"2","author":"EZ Fisman","year":"2003","unstructured":"Fisman EZ, Motro M, Tenenbaum A. Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol. 2003;2:11.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR3","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720\u201332.","journal-title":"Blood"},{"key":"573_CR4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","volume":"312","author":"ML O\u2019Donoghue","year":"2014","unstructured":"O\u2019Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP, SOLID-TIMI 52 Investigators, Steen DL. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA. 2014;312:1006\u201315.","journal-title":"JAMA"},{"key":"573_CR5","unstructured":"Novartis. Novartis phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack (press release). 2017. \n                        https:\/\/www.novartis.com\/news\/-releases\/novartis-phase-iii-study-shows-acz885-canakinumab-reduces-cardiovascmediaular-risk\n                        \n                    . Accessed 29 June 2017."},{"key":"573_CR6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12933-015-0288-y","volume":"14","author":"Z Liu","year":"2015","unstructured":"Liu Z, Zhao N, Zhu H, Zhu S, Pan S, Xu J, Zhang X, Zhang Y, Wang J. Circulating interleukin-1\u03b2 promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2. Cardiovasc Diabetol. 2015;14:125.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12933-016-0441-2","volume":"15","author":"V Moreno-Viedma","year":"2016","unstructured":"Moreno-Viedma V, Amor M, Sarabi A, Bilban M, Staffler G, Zeyda M, Stulnig TM. Common dysregulated pathways in obese adipose tissue and atherosclerosis. Cardiovasc Diabetol. 2016;15:120.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12933-016-0479-1","volume":"15","author":"Y Obata","year":"2016","unstructured":"Obata Y, Maeda N, Yamada Y, Yamamoto K, Nakamura S, Yamaoka M, Tanaka Y, Masuda S, Nagao H, Fukuda S, Fujishima Y, Kita S, Nishizawa H, Funahashi T, Matsubara KI, Matsuzawa Y, Shimomura I. Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects. Cardiovasc Diabetol. 2016;15:159.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR9","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1194\/jlr.M800019-JLR200","volume":"49","author":"I Murano","year":"2008","unstructured":"Murano I, Barbatelli G, Parisani V, Latini C, Muzzonigro G, Castellucci M, Cinti S. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res. 2008;49:1562\u20138.","journal-title":"J Lipid Res"},{"key":"573_CR10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbrc.2011.11.114","volume":"417","author":"T Yoshizaki","year":"2012","unstructured":"Yoshizaki T, Kusunoki C, Kondo M, Yasuda M, Kume S, Morino K, Sekine O, Ugi S, Uzu T, Nishio Y, Kashiwagi A, Maegawa H. Autophagy regulates inflammation in adipocytes. Biochem Biophys Res Commun. 2012;417:352\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"573_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12933-015-0208-1","volume":"14","author":"C Vavruch","year":"2015","unstructured":"Vavruch C, L\u00e4nne T, Fredrikson M, Lindstr\u00f6m T, \u00d6stgren CJ, Nystrom FH. Serum leptin levels are independently related to the incidence of ischemic heart disease in a prospective study of patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:62.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12933-016-0443-0","volume":"15","author":"RM Costa da","year":"2016","unstructured":"da Costa RM, Neves KB, Mestriner FL, Louzada-Junior P, Bruder-Nascimento T, Tostes RC. TNF-\u03b1 induces vascular insulin resistance via positive modulation of PTEN and decreased Akt\/eNOS\/NO signaling in high fat diet-fed mice. Cardiovasc Diabetol. 2016;15:119.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Investig. 2005;115:1111\u20139.","journal-title":"J Clin Investig"},{"key":"573_CR14","doi-asserted-by":"crossref","first-page":"9850","DOI":"10.1074\/jbc.M210811200","volume":"278","author":"G Charriere","year":"2003","unstructured":"Charriere G, Cousin B, Arnaund E, Andr\u00e9 M, Bacou F, P\u00e9nicaud L, et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem. 2003;278:9850\u20135.","journal-title":"J Biol Chem"},{"key":"573_CR15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12933-016-0433-2","volume":"15","author":"VH Pereira","year":"2016","unstructured":"Pereira VH, Marques F, Lages V, Pereira FG, Patchev A, Almeida OF, Almeida-Palha J, Sousa N, Cerqueira JJ. Glucose intolerance after chronic stress is related with downregulated PPAR-\u03b3 in adipose tissue. Cardiovasc Diabetol. 2016;15:114.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.mehy.2011.02.041","volume":"76","author":"SH Garland","year":"2011","unstructured":"Garland SH. Short chain fatty acids may elicit an innate immune response from preadipocytes: a potential link between bacterial infection and inflammatory diseases. Med Hypotheses. 2011;76:881\u20133.","journal-title":"Med Hypotheses"},{"key":"573_CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","volume":"9","author":"A Guilherme","year":"2008","unstructured":"Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"573_CR18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.7150\/ijms.14110","volume":"13","author":"J Janowska","year":"2016","unstructured":"Janowska J, Chudek J, Olszanecka-Glinianowicz M, Semik-Grabarczyk E, Zahorska-Markiewicz B. Interdependencies among selected pro-inflammatory markers of endothelial dysfunction, C-peptide, anti-inflammatory interleukin-10 and glucose metabolism disturbance in obese women. Int J Med Sci. 2016;13(7):490\u20139.","journal-title":"Int J Med Sci"},{"key":"573_CR19","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1152\/ajpendo.00302.2006","volume":"292","author":"SJ Creely","year":"2007","unstructured":"Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007;292:E740\u20137.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"573_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/169420","author":"O B\u0103dulescu","year":"2013","unstructured":"B\u0103dulescu O, B\u0103descu C, Ciocoiu M, B\u0103descu M. Interleukin-1-beta and dyslipidemic syndrome as major risk factors for thrombotic complications in type 2 diabetes mellitus. Mediat Inflamm. 2013. doi:\n                        10.1155\/2013\/169420\n                        \n                    .","journal-title":"Mediat Inflamm"},{"key":"573_CR21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12933-016-0397-2","volume":"15","author":"C Peir\u00f3","year":"2016","unstructured":"Peir\u00f3 C, Romacho T, Azcutia V, Villalobos L, Fern\u00e1ndez E, Bola\u00f1os JP, Moncada S, S\u00e1nchez-Ferrer CF. Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway. Cardiovasc Diabetol. 2016;15:82.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12933-016-0369-6","volume":"15","author":"AO Odegaard","year":"2016","unstructured":"Odegaard AO, Jacobs DR Jr, Sanchez OA, Goff DC Jr, Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016;15:51.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12933-016-0406-5","volume":"15","author":"Y Du","year":"2016","unstructured":"Du Y, Ji Q, Cai L, Huang F, Lai Y, Liu Y, Yu J, Han B, Zhu E, Zhang J, Zhou Y, Wang Z, Zhao Y. Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis. Cardiovasc Diabetol. 2016;15:90.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK\u03b2 and NF-\u03baB. Nat Med. 2005;11:183\u201390.","journal-title":"Nat Med"},{"key":"573_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-015-0195-2","volume":"14","author":"SA Peeters","year":"2015","unstructured":"Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Schalkwijk CG, Stehouwer CD, EURODIAB Prospective Complications Study Group. Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Cardiovasc Diabetol. 2015;14:31.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/00365513.2011.586470","volume":"71","author":"AB Mathiasen","year":"2011","unstructured":"Mathiasen AB, Harutyunyan MJ, J\u00f8rgensen E, Helqvist S, Ripa R, G\u00f8tze JP, Johansen JS, Kastrup J. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease. Scand J Clin Lab Investig. 2011;71:439\u201347.","journal-title":"Scand J Clin Lab Investig"},{"key":"573_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-015-0287-z","volume":"14","author":"E Aguilera","year":"2015","unstructured":"Aguilera E, Serra-Planas E, Granada ML, Pellitero S, Reverter JL, Alonso N, Soldevila B, Mauricio D, Puig-Domingo M. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population. Cardiovasc Diabetol. 2015;14:121.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.atherosclerosis.2012.03.034","volume":"222","author":"K Batinic","year":"2012","unstructured":"Batinic K, H\u00f6baus C, Grujicic M, Steffan A, Jelic F, Lorant D, H\u00f6rtenhuber T, Hoellerl F, Brix JM, Schernthaner G, Koppensteiner R, Schernthaner GH. YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes. Atherosclerosis. 2012;222:557\u201363.","journal-title":"Atherosclerosis"},{"key":"573_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-016-0437-y","volume":"15","author":"T Sawada","year":"2016","unstructured":"Sawada T, Tsubata H, Hashimoto N, Takabe M, Miyata T, Aoki K, Yamashita S, Oishi S, Osue T, Yokoi K, Tsukishiro Y, Onishi T, Shimane A, Taniguchi Y, Yasaka Y, Ohara T, Kawai H, Yokoyama M. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial. Cardiovasc Diabetol. 2016;15:121.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.diabres.2017.02.019","volume":"127","author":"L Merone","year":"2017","unstructured":"Merone L, McDermott R. Nutritional anti-inflammatories in the treatment and prevention of type 2 diabetes mellitus and the metabolic syndrome. Diabetes Res Clin Pract. 2017;127:238\u201353.","journal-title":"Diabetes Res Clin Pract"},{"issue":"14","key":"573_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12933-015-0254-8","volume":"30","author":"G Derosa","year":"2015","unstructured":"Derosa G, Mugellini A, Pesce RM, D\u2019Angelo A, Maffioli P. A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk. Cardiovasc Diabetol. 2015;30(14):95.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nut.2015.09.010","volume":"32","author":"N Steckhan","year":"2016","unstructured":"Steckhan N, Hohmann CD, Kessler C, Dobos G, Michalsen A, Cramer H. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis. Nutrition. 2016;32:338\u201348.","journal-title":"Nutrition"},{"key":"573_CR33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jacc.2006.03.052","volume":"48","author":"D Giugliano","year":"2006","unstructured":"Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006;48:677\u201385.","journal-title":"J Am Coll Cardiol"},{"key":"573_CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-016-0473-7","volume":"15","author":"H Kusaka","year":"2016","unstructured":"Kusaka H, Koibuchi N, Hasegawa Y, Ogawa H, Kim-Mitsuyama S. Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome. Cardiovasc Diabetol. 2016;15:157.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12933-016-0480-8","volume":"15","author":"M Rizzo","year":"2016","unstructured":"Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G, Li Volti G, Caprio M, Montalto G, Provenzano V, Genovese S, Ceriello A. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study. Cardiovasc Diabetol. 2016;15:162.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR36","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/138161212799504803","volume":"18","author":"AS Antonopoulos","year":"2012","unstructured":"Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des. 2012;18:1519\u201330.","journal-title":"Curr Pharm Des"},{"key":"573_CR37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12933-015-0294-0","volume":"14","author":"EZ Fisman","year":"2015","unstructured":"Fisman EZ, Tenenbaum A. Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes. Cardiovasc Diabetol. 2015;14:129.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10557-014-6539-4","volume":"28","author":"Y Dai","year":"2014","unstructured":"Dai Y, Dai D, Wang X, Ding Z, Mehta JL. DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1\u03b2 via GLP-1 receptor in macrophages through protein kinase C pathway. Cardiovasc Drugs Ther. 2014;28:425\u201332.","journal-title":"Cardiovasc Drugs Ther"},{"key":"573_CR39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11883-014-0435-z","volume":"16","author":"E Golia","year":"2014","unstructured":"Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I, Bianchi R, Crisci M, D\u2019Acierno L, Giordano R, Di Palma G, Conte M, Golino P, Russo MG, Calabr\u00f2 R, Calabr\u00f2 P. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16:435.","journal-title":"Curr Atheroscler Rep"},{"key":"573_CR40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12933-017-0551-5","volume":"16","author":"A Younis","year":"2017","unstructured":"Younis A, Eskenazi D, Goldkorn R, Leor J, Naftali-Shani N, Fisman EZ, Tenenbaum A, Goldenberg I, Klempfner R. The addition of vildagliptin to metformin prevents the elevation of interleukin 1\u00df in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study. Cardiovasc Diabetol. 2017;16:69.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR41","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/embor.2012.142","volume":"13","author":"P Hunter","year":"2012","unstructured":"Hunter P. The inflammation theory of disease. EMBO Rep. 2012;13:968\u201370.","journal-title":"EMBO Rep"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-017-0573-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T09:00:01Z","timestamp":1500454801000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-017-0573-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["573"],"URL":"https:\/\/doi.org\/10.1186\/s12933-017-0573-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]},"article-number":"91"}}